Aveta System
- Industry
- Surgical Devices
- Founded Year
- 2016
- Headquarters
- San Jose, CA
- Employee Count
- 11
Key People
- Csaba Truckai - Co-Founder, Chief Executive Officer, President & Board Member
- John Shadduck - Co-Founder, IP Counsel, President & Board Member
- Nora Wu - Board Member
- Steven Hochberg - Board Member
- William Dai - Board Member
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced MedTech entrepreneurs with a history of successful ventures.
The presence of multiple successful MedTech entrepreneurs in the leadership team suggests a strong foundation for strategic decision-making and industry navigation.
- Clinical Need
-
Aspect: Very Strong
Summary: The Aveta System addresses a significant need for efficient, minimally invasive gynecological procedures.
By offering an all-in-one solution for intrauterine pathology, the Aveta System caters to the growing preference for minimally invasive surgical options, enhancing patient outcomes and procedural efficiency.
- Competition
-
Aspect: Somewhat crowded
Summary: The market for surgical devices in gynecology has several established players.
The presence of multiple competitors necessitates differentiation through innovation and superior value propositions to capture market share.
- Technical Challenge
-
Aspect: Predictable
Summary: The development of the Aveta System involves manageable technical challenges.
Given the team's background and the nature of the product, the technical challenges are likely within the company's capabilities to address effectively.
- Patent
-
Aspect: Strong
Summary: The company holds strong patents protecting its technology.
Strong patent protection can deter competitors and provide leverage in the market, contributing to the company's long-term success.
- Financing
-
Aspect: Well-funded
Summary: The company has secured significant funding from reputable investors.
The backing from investors like Deerfield Management and Horizon Technology Finance indicates confidence in the company's potential and provides the necessary resources for growth.
- Regulatory
-
Aspect: 510k/PMA
Summary: The Aveta System is progressing through the FDA clearance process.
Navigating the FDA clearance process is a critical step, and the company's progress in this area is essential for commercialization.
Opportunity Rollup
- Odds of Success
- 3.5
- Peak Market Share
- 4.4
- Segment CAGR
- 10.7%
- Market Segment
- Surgical Devices
- Market Sub Segment
- Minimally Invasive Gynecology
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.22 |
| 2 | 0.66 |
| 3 | 1.54 |
| 4 | 3.08 |
| 5 | 4.40 |
Key Takeaway
Aveta System, with its experienced team and innovative product, is well-positioned to capitalize on the growing demand for minimally invasive gynecological procedures, despite facing a competitive market and regulatory challenges.